Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Programs Update
March 04, 2016 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 04, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), which is developing next-generation medicines for fibromyalgia and post-traumatic stress...
Tonix Pharmaceuticals to Present at Two Investor Conferences in March 2016
March 03, 2016 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 03, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), which is developing next-generation medicines for fibromyalgia and post-traumatic stress...
Tonix Pharmaceuticals Appoints Chief Financial Officer
February 25, 2016 16:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Feb. 25, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), which is developing next-generation medicines for fibromyalgia and post-traumatic stress...
Tonix Pharmaceuticals Reports Top Line Results From Phase 2 Proof-of-Concept Clinical Study of TNX-201 in Episodic Tension-Type Headache
February 16, 2016 08:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), which is developing next-generation medicines for fibromyalgia and post-traumatic stress...
Tonix Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference
February 02, 2016 07:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), which is developing next-generation medicines for fibromyalgia, post-traumatic stress...
Tonix Pharmaceuticals Announces Management Change
January 08, 2016 16:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (“Tonix”), which is developing next-generation medicines for fibromyalgia, post-traumatic stress...
Tonix Pharmaceuticals to Present at Biotech Showcase 2016
January 05, 2016 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (“Tonix”), which is developing next-generation medicines for fibromyalgia, post-traumatic stress...
Tonix Pharmaceuticals Completes Enrollment in Phase 2 Clinical Trial of TNX-102 SL in Post-Traumatic Stress Disorder (PTSD)
December 23, 2015 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Dec. 23, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (“Tonix”), which is developing next-generation medicines for fibromyalgia, post-traumatic stress...
Tonix Pharmaceuticals Completes Enrollment in Phase 2 Clinical Study of TNX-201 in Episodic Tension-Type Headache
December 08, 2015 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Dec. 8, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder...
Tonix Pharmaceuticals and U.S. Department of Defense Military Developer in Partnership to Expand Efforts to Examine TNX-102 SL for Post-Traumatic Stress Disorder
December 07, 2015 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder...